Nuvation Bio Inc.
NUVB
$2.23
-$0.13-5.51%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.08M | 5.71M | 727.00K | 1.44M | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.08M | 5.71M | 727.00K | 1.44M | -- |
| Cost of Revenue | 2.09M | 4.22M | 1.52M | 1.35M | -- |
| Gross Profit | 990.00K | 1.50M | -788.00K | 88.00K | -- |
| SG&A Expenses | 35.39M | 26.14M | 19.58M | 16.16M | 7.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.09M | 59.65M | 48.83M | 471.82M | 20.20M |
| Operating Income | -59.00M | -53.94M | -48.10M | -470.39M | -20.20M |
| Income Before Tax | -53.24M | -49.45M | -41.21M | -462.49M | -14.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -53.24M | -49.45M | -41.21M | -462.49M | -14.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.24M | -49.45M | -41.21M | -462.49M | -14.79M |
| EBIT | -59.00M | -53.94M | -48.10M | -470.39M | -20.20M |
| EBITDA | -58.69M | -53.72M | -47.94M | -470.14M | -20.14M |
| EPS Basic | -0.16 | -0.15 | -0.15 | -1.89 | -0.07 |
| Normalized Basic EPS | -0.10 | -0.09 | -0.09 | -1.18 | -0.04 |
| EPS Diluted | -0.16 | -0.15 | -0.15 | -1.89 | -0.07 |
| Normalized Diluted EPS | -0.10 | -0.09 | -0.09 | -1.18 | -0.04 |
| Average Basic Shares Outstanding | 338.61M | 336.93M | 273.57M | 244.74M | 219.05M |
| Average Diluted Shares Outstanding | 338.61M | 336.93M | 273.57M | 244.74M | 219.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |